Nanoviricides Inc (NNVC)
1.11
-0.04
(-3.48%)
USD |
NYAM |
Apr 25, 16:00
1.12
+0.01
(+0.90%)
After-Hours: 20:00
Nanoviricides Price to Book Value: 1.050 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.050 |
| April 24, 2024 | 1.088 |
| April 23, 2024 | 1.078 |
| April 22, 2024 | 1.060 |
| April 19, 2024 | 1.041 |
| April 18, 2024 | 1.112 |
| April 17, 2024 | 1.097 |
| April 16, 2024 | 1.116 |
| April 15, 2024 | 1.088 |
| April 12, 2024 | 1.182 |
| April 11, 2024 | 1.201 |
| April 10, 2024 | 1.239 |
| April 09, 2024 | 1.287 |
| April 08, 2024 | 1.315 |
| April 05, 2024 | 1.296 |
| April 04, 2024 | 1.296 |
| April 03, 2024 | 1.211 |
| April 02, 2024 | 1.201 |
| April 01, 2024 | 1.230 |
| March 28, 2024 | 1.097 |
| March 27, 2024 | 1.069 |
| March 26, 2024 | 1.078 |
| March 25, 2024 | 1.069 |
| March 22, 2024 | 1.078 |
| March 21, 2024 | 1.078 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.088 |
| March 19, 2024 | 1.088 |
| March 18, 2024 | 1.088 |
| March 15, 2024 | 1.135 |
| March 14, 2024 | 1.107 |
| March 13, 2024 | 1.069 |
| March 12, 2024 | 1.069 |
| March 11, 2024 | 1.060 |
| March 08, 2024 | 1.050 |
| March 07, 2024 | 1.069 |
| March 06, 2024 | 1.097 |
| March 05, 2024 | 1.145 |
| March 04, 2024 | 1.145 |
| March 01, 2024 | 1.192 |
| February 29, 2024 | 1.277 |
| February 28, 2024 | 1.249 |
| February 27, 2024 | 1.258 |
| February 26, 2024 | 1.258 |
| February 23, 2024 | 1.258 |
| February 22, 2024 | 1.201 |
| February 21, 2024 | 1.173 |
| February 20, 2024 | 1.173 |
| February 16, 2024 | 1.164 |
| February 15, 2024 | 1.126 |
| February 14, 2024 | 1.107 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5227
Minimum
May 12 2022
16.11
Maximum
Jan 31 2020
1.670
Average
1.238
Median
Dec 23 2020
Price to Book Value Benchmarks
| Gilead Sciences Inc | 3.561 |
| NovaBay Pharmaceuticals Inc | 1.699 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6516 |
| Theriva Biologics Inc | 0.1902 |
Price to Book Value Related Metrics
| Price | 1.11 |
| Earnings Yield | -72.97% |
| Market Cap | 13.07M |